1. Market Research
  2. > Therapy
View report >

Antibe Therapeutics Inc. - Analyst Report, June 2018

  • June 2018
  • 2 pages

ATB-##, a HS releasing derivative of aspirin, is in preclinical development and is aimed as a chronic low-dose long-term anti-thrombotic drug that could avoid the GI distress associated with aspirin.

  • Analgesic
  • Anti Rheumatic
  • Salicylic Acid
  • Therapy
  • Antibe Therapeutics Inc.

Therapy Market in the US November 2001

OTC Industry in the US January 2004

US Market Report for Ankylosing Spondylitis Immunology Drugs 2018 - MedCore

  • $ 2995
  • October 2017
  • 928 pages

The medication treatment includes nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, naproxen, and aspirin.

  • Anti Rheumatic
  • Medical Biotechnology
  • Monoclonal Antibody
  • Salicylic Acid
  • Therapy

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on